Ilic Nenad, Petricevic Ante, Arar Dragan, Kotarac Slavica, Banovic Josip, Ilic Nives Frleta, Tripkovic Andro, Grandic Leo
Department of Thoracic Surgery, University Surgical Hospital, Split, Croatia.
J Thorac Oncol. 2007 Nov;2(11):1018-21. doi: 10.1097/JTO.0b013e318158d471.
To study the incidence and characteristics of mediastinal nodal metastases without N1 nodal metastases (skip N2 metastases) in patients with resected pIII/A/N2 non-small cell lung cancer.
A total of 323 non-small cell lung cancer patients who underwent radical surgical resection with a systematic mediastinal nodal dissection in 4-year period (2000-2003) were retrospectively reviewed. The 85 patients (26%) at stage IIIA/N2 (pN2+) were grouped according to their skip metastases status. Patient data were statistically analyzed.
Skip N2 metastases were found in 21 patients (25%) without N1 nodal involvement. The postoperative survival for skip N2 disease was almost the same as that for pN2 disease with N1 nodal involvement. The incidence of N2 metastases seemed to be more frequent in adenocarcinoma patients (p < 0.005), but skip N2 metastases were significantly higher (p < 0.001) in squamous cell carcinoma patients. Although skip metastases involved more often upper mediastinal lymph nodes and one station level, the difference was not found statistically significant (p < 0.227). Complication rate showed no difference between analyzed groups of patients.
Sample mediastinal lymphadenectomy may not be appropriate in surgery for non-small cell lung cancer because skip metastases were found in 25% of patients without N1 nodal involvement.
研究接受手术切除的pIII/A/N2期非小细胞肺癌患者中无N1淋巴结转移(跳跃性N2转移)的纵隔淋巴结转移的发生率及特征。
回顾性分析2000年至2003年期间接受根治性手术切除并系统性纵隔淋巴结清扫的323例非小细胞肺癌患者。85例(26%)IIIA/N2期(pN2+)患者根据其跳跃性转移状态分组。对患者数据进行统计学分析。
在21例(25%)无N1淋巴结受累的患者中发现了跳跃性N2转移。跳跃性N2疾病患者的术后生存率与有N1淋巴结受累的pN2疾病患者几乎相同。腺癌患者中N2转移的发生率似乎更高(p<0.005),但鳞状细胞癌患者的跳跃性N2转移明显更高(p<0.001)。尽管跳跃性转移更常累及上纵隔淋巴结且为一站水平,但差异无统计学意义(p<0.227)。分析的患者组之间并发症发生率无差异。
对于非小细胞肺癌手术,样本纵隔淋巴结切除术可能不合适,因为在25%无N1淋巴结受累的患者中发现了跳跃性转移。